Solutions / R&D and Clinical
Trial DesignClinical trial design and feasibility, benchmarked to your peers
Side-by-side trial details and customizable peer aggregates so you can ground endpoints, inclusion and exclusion criteria, enrollment targets, timelines, and feasibility in what comparable trials actually did.
- 740,000+ trials
- Refreshed daily
- Source-traceable
- Deep China coverage
Design trials with peer benchmarks and comparators
Build a peer set from 740,000+ source-traceable trials, then benchmark the choices that shape a protocol, from endpoints to enrollment, so your design decisions rest on precedent rather than assumptions.
Explore clinical trial details
View each trial's study outline as provided by global registries for side-by-side comparison across indication, endpoints, inclusion and exclusion criteria, enrollment, site locations, investigators, contact information, and more.
Build a custom comparator set
Assemble the exact set of comparable trials by indication, phase, modality, geography, specific sponsors, and more, then benchmark against it.
Benchmark design choices
Establish aggregate study duration, target vs actual enrollment, site counts, and more to set benchmarks and identify what is standard vs. what is differentiated.
Pressure-test feasibility
Assess whether a design is feasible before you commit, using real precedent across sites, geographies, and timelines.
An example benchmark, ready in minutes
DMD gene therapy benchmark
18gene-therapy trials
Every Duchenne muscular dystrophy gene-therapy trial on record, tiny first-in-human cohorts, multi-year follow-up, and overwhelmingly US-based.
All figures shown are medians across the cohort.
Where DMD Gene-Therapy Trials Run
Trials with site activity by region, bubble size = trial count
| Region | Trials |
|---|